Screener
Opko Health OPK Diagnostics — Research And Development Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| (In thousands) / Revenue from services: / Pharmaceutical | For the three months ended June 30, 2026 / — | For the three months ended June 30, 2025 / — | For the six months ended June 30, 2026 / — | For the six months ended June 30, 2025 / — |
|---|---|---|---|---|
| $52,924 | $59,597 | $101,531 | $118,683 | |
| Research and development: | ||||
| Pharmaceutical | $32,739 | $29,778 | $61,492 | $60,016 |
| Diagnostics | 294 | 484 | 606 | 1,022 |
| Corporate | 133 | 80 | 267 | 145 |
| $33,166 | $30,342 | $62,365 | $61,183 | |
| Amortization of intangible assets: | ||||
| Pharmaceutical | $16,436 | $16,415 | $32,869 | $32,525 |
Item 1. Financial Statements
FAQ
- What is Opko Health's diagnostics — research and development expense?
- Opko Health (OPK) reported diagnostics — research and development expense of $294K in Q2 2026.
- How has Opko Health's diagnostics — research and development expense changed year-over-year?
- Opko Health's diagnostics — research and development expense decreased by 39.3% year-over-year, from $484K to $294K.
- What is the long-term trend for Opko Health's diagnostics — research and development expense?
- Over 3 years (2022 to 2025), Opko Health's diagnostics — research and development expense has grown at a -48.6% compound annual growth rate (CAGR), from $12.02M to $1.64M.
- What does diagnostics — research and development expense mean?
- Represents the costs incurred for developing new diagnostic technologies, improving existing testing methodologies, and clinical validation. This investment is vital for maintaining a competitive edge in the rapidly evolving diagnostics market. High spending indicates a commitment to innovation and future product pipeline expansion.
Ask your AI about Opko Health's diagnostics — research and development expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude